National Syndromic Surveillance Program Public Comment Period
The Centers for Disease Control and Prevention (CDC) announced the closure of the public comment period for the National Syndromic Surveillance Program (NSSP). The comment period ended on February 5, 2025. This notice serves as an update on the status of the program's public consultation phase.
Meningitis Patient Factsheet and Vaccination Advice
The MHRA has published a patient factsheet on meningitis, providing information on the condition, its causes, symptoms, and the role of vaccination. The guidance also advises on reporting vaccine side effects through the Yellow Card scheme.
USPTO Patent Grant for Polypeptide Reagent Kit
The USPTO has granted a patent (US12578329B2) to Shimadzu Corporation for a reagent kit containing polypeptides designed for detecting intermolecular interactions. The patent details specific amino acid sequences and their modifications for use in this kit.
Microsoft Technology Licensing, LLC Awarded Patent for Anti-lock Hinged Device
The USPTO has granted Microsoft Technology Licensing, LLC a patent for an anti-lock hinged device. The patent, US12577979B2, describes a mechanism designed to prevent over-extension in hinged devices. The filing date for this patent application was October 23, 2023.
USPTO Grants Patent for Single Molecule Peptide Sequencing
The USPTO has granted a patent (US12578345B2) to The University of Texas System for methods of single molecule peptide sequencing. The patent covers techniques for identifying polypeptide sequences within a mixture by immobilizing, labeling, and analyzing the polypeptide.
USPTO Patent for Alzheimer's Detection Kits
The USPTO has granted a patent (US12578344B2) to NEUROQUEST LTD. for compositions, kits, and methods for detecting preclinical Alzheimer's Disease. The patent covers binding agents for biomarkers such as CD163 and scavenger receptors, and methods for diagnosing AD and assessing therapeutic efficacy.
USPTO Patent Grant: Canine TK1 Protein Determination Kit
The USPTO has granted patent US12578340B2 to ALERTIX VETERINARY DIAGNOSTICS AB for a kit to determine canine TK1 protein levels. The kit utilizes specific monoclonal antibodies to detect peptides from canine TK1.
Samsung Display Patent for Organic Compound Sensor Display
The USPTO has granted Samsung Display Co., Ltd. a patent for an organic compound sensor display. The patent, US12581853B2, covers an organic compound represented by Chemical Formula 1 and its application in sensor-embedded display panels and electronic devices. The filing date was September 28, 2022.
USPTO Patent Grant for Light-Emitting Element
The USPTO has granted patent US12581794B2 for a light-emitting element developed by Semiconductor Energy Laboratory Co., Ltd. The patent covers a specific design for a light-emitting element utilizing a phosphorescent compound and an exciplex formed by organic compounds.
USPTO Patent Grant: Bioprobes for Amine Oxidase Enzymes
The USPTO has granted a patent (US12578335B2) to Syntara Limited for novel bioprobes designed to detect and quantify amine oxidase enzymes. These bioprobes are intended for use in assessing enzyme concentrations and inhibition levels in various samples.
USPTO Patent Grant US12581852B2 for Luminescent Material
The United States Patent and Trademark Office (USPTO) has granted patent US12581852B2 to KYULUX, INC. for a compound useful as a light-emitting material. The patent covers specific chemical formulas and their application in organic optical devices.
USPTO Patent Grant for Bispecific Antibodies
The USPTO has granted a patent (US12577314B2) to ABL BIO INC. for bispecific antibodies designed to treat diseases related to BCMA and/or 4-1BB proteins. The patent covers the antibody's structure and its therapeutic applications.
US Patent 12577313B2 for Bispecific Antibodies
The USPTO has granted US Patent 12577313B2 for bispecific antibodies targeting claudin 18.2 and 4-1BB, assigned to I-Mab Biopharma US Limited. The patent covers novel antibody designs that can trigger tumor-specific immune responses.
Anti-CSF1R Antibodies and Pharmaceutical Compositions Patent
The USPTO has granted patent US12577309B2 for anti-CSF1R antibodies, pharmaceutical compositions, and their uses. The patent was assigned to DRAGONBOAT BIOPHARMACEUTICAL (SHANGHAI) CO., LTD. and lists six inventors. The patent's abstract describes antibodies against human CSF-1R.
USPTO Patent Grant: Diagnostic Antibodies Against MUC17
The USPTO has granted patent US12577322B2 to Amgen Inc. for diagnostic antibodies against mucin 17 (MUC17). These antibodies and associated detection systems are intended for detecting, quantifying, and monitoring MUC17 related to disease diagnosis, progression, and therapeutic response.
FEMA National Fire Department Registry Collection Proposed
The Federal Emergency Management Agency (FEMA) is proposing to establish a National Fire Department Registry. This notice requests public comment on the proposed information collection activity, which aims to gather data on fire departments across the nation. The comment period closes on April 13, 2026.
FEMA Grants Reporting Tool Proposed Collection Comment Request
The Federal Emergency Management Agency (FEMA) is requesting public comments on a proposed new information collection activity related to its Grants Reporting Tool (GRT). This notice initiates a 22-day comment period for stakeholders to provide feedback on the proposed data collection requirements for FEMA grants.
Proposed Flood Hazard Determinations
The Federal Emergency Management Agency (FEMA) has published proposed flood hazard determinations. This notice initiates a comment period for affected parties to provide input on these proposed changes to flood hazard maps and data.
Proposed Flood Hazard Determinations
The Federal Emergency Management Agency (FEMA) has published proposed flood hazard determinations. This notice initiates a comment period for affected parties to provide input on these proposed changes to flood hazard maps.
Proposed Flood Hazard Determinations by FEMA
The Federal Emergency Management Agency (FEMA) has proposed new flood hazard determinations. This notice opens a public comment period for affected parties to submit feedback on the proposed changes.
Proposed Flood Hazard Determinations by FEMA
The Federal Emergency Management Agency (FEMA) has proposed flood hazard determinations. These proposed determinations outline areas identified as having specific flood risks. The public has an opportunity to comment on these proposed changes.
Agency Information Collection Activities: FEMA Disaster Case Management
The Federal Emergency Management Agency (FEMA) has submitted an information collection request for the FEMA-Administered Disaster Case Management program for OMB review. This notice provides a 60-day period for public comment on the reinstatement of this collection.
FEMA THIRA/SPR Unified Reporting Tool Collection Proposed
The Federal Emergency Management Agency (FEMA) is proposing a new collection of information for the Threat and Hazard Identification and Risk Assessment (THIRA)/Stakeholder Preparedness Review (SPR) Unified Reporting Tool. FEMA is seeking public comment on this proposed collection.
Agency Information Collection Proposed Comment Request: Environmental and Historic Preservation Screening Form
The Federal Emergency Management Agency (FEMA) has published a notice requesting public comment on a proposed collection of information related to an Environmental and Historic Preservation Screening Form. The comment period is open for 22 days.